Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Critical Reviews in Oral Biology & Medicine
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cha, S.
Right arrow Articles by Humphreys-Beher, M.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
13(1):5-16 (2002)     Crit Rev Oral Biol Med
© 2002 International and American Associations for Dental Research

PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE

S. Cha1,*, A.B. Peck2 and M.G. Humphreys-Beher1,{dagger}

1 Departments of Oral Biology and
2 Pathology, Immunology & Laboratory Medicine, PO Box 100424, University of Florida, Gainesville, FL 32610

Correspondence: * corresponding author, scha{at}dental.ufl.edu

Sjögren's Syndrome (SS) is a chronic autoimmune disease characterized by histological and functional alterations of salivary and lacrimal glands that result in a severe dryness of the mouth and the eyes. The etiology of SS has remained undefined despite investigators' significant efforts to identify the mechanisms of initiation. Based on histopathology, several animal models are available—such as MRL/lpr, NZW/NZB, NFS/sld, graft vs. host, transgenic mouse expressing viral surface antigen, and the non-obese diabetic (NOD) mouse—for investigation of the etiology of SS. Biochemical and immunological similarities between human SS and autoimmune exocrinopathy (AEC) in the NOD mouse, including the loss of secretory function, establish the NOD mouse as an appropriate model to unravel the underlying pathophysiology of SS. Recently, several NOD congenic partner strains have been developed to investigate the roles of genetic intervals, cytokines, and autoantibodies in the disease pathogenesis. Studies on NOD-scid suggest that the pathogenesis of SS occurs in two phases: an asymptomatic phase, in which epithelial cells of exocrine tissues undergo dedifferentiation accompanied by elevated apoptosis; and a second phase in which autoaggression is mounted against target organ autoantigens, resulting in the activation of T- and B-cells, and the generation of autoantibodies. The presence of autoantibodies on the cell-surface signaling receptor, the muscarinic3 receptor, in both SS patients and the NOD mice correlates with the hallmark clinical symptom of secretory dysfunction. Additionally, the NOD mouse model provides an important example of how both Th1 and Th2 cytokines, as well as non-immune genetic loci, are involved in the maintenance of and progression to the overt disease state. Ultimately, analysis of these data provides insight into potentially novel therapeutic interventions.

Key Words: Sjögren's syndrome • autoimmune exocrinopathy • animal models • NOD mice • pathogenesis

Critical Reviews in Oral Biology & Medicine, Vol. 13, No. 1, 5-16 (2002)
DOI: 10.1177/154411130201300103


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. E. Doyle, L. Boggs, R. Attia, L. R. Cooper, D. R. Saban, C. Q. Nguyen, and A. B. Peck
Autoimmune Dacryoadenitis of NOD/LtJ Mice and Its Subsequent Effects on Tear Protein Composition
Am. J. Pathol., October 1, 2007; 171(4): 1224 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Q. Nguyen, H. Kim, J. G. Cornelius, and A. B. Peck
Development of Sjogren's Syndrome in Nonobese Diabetic-Derived Autoimmune-Prone C57BL/6.NOD-Aec1Aec2 Mice Is Dependent on Complement Component-3
J. Immunol., August 15, 2007; 179(4): 2318 - 2329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Q. Nguyen, J.-h. Gao, H. Kim, D. R. Saban, J. G. Cornelius, and A. B. Peck
IL-4-STAT6 Signal Transduction-Dependent Induction of the Clinical Phase of Sjogren's Syndrome-Like Disease of the Nonobese Diabetic Mouse
J. Immunol., July 1, 2007; 179(1): 382 - 390.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B M Lodde, B J Baum, P P Tak, and G Illei
Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment
Ann Rheum Dis, November 1, 2006; 65(11): 1406 - 1413.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B M Lodde, F Mineshiba, J Wang, A P Cotrim, S Afione, P P Tak, and B J Baum
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome
Ann Rheum Dis, February 1, 2006; 65(2): 195 - 200.
[Abstract] [Full Text] [PDF]